September 10, 2025Zeitschrift für Gastroenterologie

Percutaneous transhepatic biliary drainage (PTBD) versus endoscopic ultrasound-guided biliary drainage (EUS-BD) with primary metal stent for unresectable malignant distal biliary obstruction (MDBO) after failed ERCP: a European prospective controlled multicenter trial (PUMa trial)

View Full Paper

Ask AI

Bookmark

EUS-BD shows potential superiority over PTBD for managing unresectable malignant distal biliary obstruction.
In the trial, patients receiving EUS-BD reported improved outcomes compared to those undergoing PTBD.
The multicenter trial used a prospective controlled approach to compare the two drainage techniques effectively.
Findings underscore the importance of evaluating biliary drainage methods for better patient management in biliary obstruction cases.

Implication

Prospective trial assesses PTBD versus EUS-BD for malignant biliary obstruction after ERCP failure, suggesting EUS-BD may be superior.

Abstract

Background: Despite the increasing use of EUS-BD, the inferiority of PTBD versus EUS-BD in patients with unresectable MDBO after failed ERCP has not been demonstrated in a prospective, multicenter, international study.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schmitz et al. (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478b76e https://doi.org/10.1055/s-0045-1811104

View Full Paper

Ask AI

Bookmark

Implication

Prospective trial assesses PTBD versus EUS-BD for malignant biliary obstruction after ERCP failure, suggesting EUS-BD may be superior.

Percutaneous transhepatic biliary drainage (PTBD) versus endoscopic ultrasound-guided biliary drainage (EUS-BD) with primary metal stent for unresectable malignant distal biliary obstruction (MDBO) after failed ERCP: a European prospective controlled multicenter trial (PUMa trial)

Key Points

Implication

Abstract

Discussion

Cite This Study

Percutaneous transhepatic biliary drainage (PTBD) versus endoscopic ultrasound-guided biliary drainage (EUS-BD) with primary metal stent for unresectable malignant distal biliary obstruction (MDBO) after failed ERCP: a European prospective controlled multicenter trial (PUMa trial)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading